| Literature DB >> 30627151 |
Tonya L Rich1, Samuel Nemanich2, Mo Chen3,4, Kathleen Friel5,6,7, Timothy Feyma8, Linda Krach9, Tanjila Nawshin1, Gregg Meekins10, Bernadette T Gillick1,2.
Abstract
Objective: We investigated the preliminary efficacy of cathodal transcranial direct current stimulation (tDCS) combined with bimanual training in children and young adults with unilateral cerebral palsy based on the principle of exaggerated interhemispheric inhibition (IHI).Entities:
Mesh:
Year: 2018 PMID: 30627151 PMCID: PMC6304908 DOI: 10.1155/2018/9610812
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Figure 1Study flow and participant diagram. MRI: magnetic resonance imaging; tDCS: transcranial direct current stimulation; TMS: transcranial magnetic stimulation.
Participant characteristics and function.
| ID | Age (y) | Sex | Lesion location | Lesion details | Affected side | MACS level | CST circuitry | Lesioned MT | Nonlesioned MT |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 8 | M | Cortical and subcortical | Left MCA distribution, frontal and parietal operculum, left PLIC, cerebral peduncle, and ventral pons | R | II | Contralateral | 52 | 46 |
| 2 | 14 | F | Subcortical | Left lateral ventricle, centrum semiovale, and internal capsule | R | II | Contralateral | 44 | 41 |
| 3 | 14 | F | Cortical and subcortical | Left lateral ventricle with adjacent thinning of cortex and corpus callosum | R | III | Contralateral | 64 | 57 |
| 4 | 10 | F | Subcortical | Left lacunar infarct in thalamus | R | II | Bilateral | 66 | 63 |
| 5 | 15 | F | Cortical and subcortical | Left MCA distribution, frontoparietal cortex, left thalamus, and basal ganglia | R | I | Bilateral | 46 | 42 |
| 6 | 19 | F | Cortical and subcortical | Right lateral ventricle and posterior right frontal lobe | L | II | Bilateral | 44 | 38 |
| 7 | 12 | M | Cortical and subcortical | Right thalamus and periventricular white matter | L | II | Bilateral | 75 | 54 |
| 8 | 8 | M | Cortical and subcortical | Left frontal lobe and posterior parietal lobe; left subinsular, caudate, and lentiform nuclei; left basal ganglia and hypothalamic region; and left cerebral peduncle | R | III | Bilateral | 77 | 48 |
CST: corticospinal tract; F: female, L: left; M: male; MACS: Manual Ability Classification System; MCA: middle cerebral artery; MT: motor threshold; PLIC: posterior limb of internal capsule; R: right; y: years. Lesion location was identified by a pediatric neurologist as cortical, subcortical, or both cortical and subcortical. CST circuitry pattern was identified with single-pulse transcranial magnetic stimulation testing.
Participant function and behavioral change scores.
| ID | Circuitry | AHA | AHA ∆ | Box and Blocks MA | Box and Blocks MA ∆ | Box and Blocks LA | Box and Blocks LA ∆ | COPM-Perf | COPM-Perf ∆ | ABILHAND | ABILHAND ∆ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Contra | 60 |
| 19.08 |
| 57.58 |
| 3.45 | 1.55 | 1.48 |
|
| 2 | Contra | 83 |
| 27.08 |
| 70.33 |
| 3.70 | 1.31 | 3.90 | 0.00 |
| 3 | Contra | 52 | 0 | 15.08 |
| 31.33 | 1 | 2.67 |
| 0.52 |
|
| 4 | Bilateral | 54 | −2 | 3.78 | 2 | 61.17 | −4 | 4.69 |
| 2.02 | 0.15 |
| 5 | Bilateral | 53 | 0 | 12.58 | −2 | 48.33 |
| 3.83 |
| 3.80 | 0.10 |
| 6 | Bilateral | 75 | 0 | 25.67 |
| 79.33 | 3 | 1.00 |
| 0.72 |
|
| 7 | Bilateral | 55 | 4 | 41.25 | 3 | 65.92 |
| 5.00 |
| 1.79 | −0.03 |
| 8 | Bilateral | 34 |
| 0 |
| 34.92 | −2 | 3.35 | 0.85 | 0.25 | −0.08 |
AHA: Assisting Hand Assessment; Contra: contralateral; COPM: Canadian Occupational Performance Measure; LA: less affected hand, MA: more affected hand; ∆: change. AHA is reported in 0–100 AHA units, Box and Blocks is reported as a mean, COPM is reported as a mean, and ABILHAND is reported in logits. Baseline testing for Box and Blocks, COPM, and ABILHAND reflects the average of 4 pretests. The change score is calculated with posttest-average baseline score. Achievement of smallest detectable difference (AHA), least measurable difference (ABILHAND), and clinically meaningful differences (COPM) are denoted in bold. Given the precision of the measurement, change in Box and Blocks that exceeds the standard error of the measure is denoted in bold (>3 blocks for MA hand and >6 blocks for LA hand).
Figure 2Individual change in behavioral measures (a) AHA with the SDD denoted with a dashed line. (b) COPM-Performance. The MCID of the COPM is denoted with a dashed line. (c) Box and Blocks with more affected hand. The SEM of repeated baseline testing with the Box and Blocks is denoted with a dashed line. AHA: Assisting Hand Assessment; COPM: Canadian Occupational Performance Measure; MCID: minimal clinically important difference; SDD: smallest detectable difference. Note: the y-axis representing change differs between the measures. Blue bars represent participants identified as a responder on the primary outcome (AHA), and black bars represent participants identified as a nonresponder on the primary outcome (AHA).
Figure 3Pre- and posttest neurophysiologic measures. (a) Nonlesioned hemisphere amplitude with single-pulse TMS testing. (b) Lesioned hemisphere amplitude with single-pulse TMS testing. (c) Nonlesioned hemisphere CSP duration. (d) Lesioned hemisphere CSP duration. Nonlesioned data is denoted by a closed circle, and lesioned data is denoted by an open circle. Note: data points are labeled with a superscript participant identifier consistent with Table 1 (participant IDs 1–8). The y-axis representing change differs between the measures. CSP: cortical silent period; ms: milliseconds; SP: single-pulse; TMS: transcranial magnetic stimulation. Amplitudes are measured in μV (microvolts).
Lesioned hemisphere cortical excitability mapping measures.
| ID | Laterality | Mapping testing intensity (% MSO) | Lesioned hemisphere | ||||
|---|---|---|---|---|---|---|---|
| Pretest FDI sites | Pretest FDI mapping latency (ms) | Posttest FDI sites | Posttest FDI mapping latency (ms) | % ∆ in FDI sites | |||
| 1 | Contralateral | † | † | † | † | † | † |
| 2 | Contralateral | 48 | 24 | 22.50 | 18 | 20.19 |
|
| 3 | Contralateral | 70 | 24 | 27.06 | 23 | 25.26 | −4.17 |
| 4 | Bilateral | † | † | † | † | † | † |
| 5 | Bilateral | 51 | 39 | 49.95 | 57 | 47.51 |
|
| 6 | Bilateral | 38 | 38 | 58.00 | 27 | 58.36 |
|
| 7 | Bilateral | † | † | † | † | † | † |
| 8 | Bilateral | † | † | † | † | † | † |
FDI: first dorsal interosseous; ID: participant identifier; ms: milliseconds; NA: not assessed at baseline; NC: not calculated due to missing baseline data; RMT: resting motor threshold; ∆: change; †: missing data; % MSO: percentage of maximum stimulator output. Motor mapping testing intensity was 110% RMT (resting motor threshold). MEP latency durations are reported using the mean time (ms). Bolded values are considered significant defined as ≥20% mapping response sites.
Nonlesioned hemisphere cortical excitability mapping measures.
| ID | Laterality | Mapping testing intensity (% MSO) | Nonlesioned hemisphere | ||||
|---|---|---|---|---|---|---|---|
| Pretest FDI sites | Pretest FDI mapping latency (ms) | Posttest FDI sites | Posttest FDI mapping latency (ms) | % ∆ in FDI sites | |||
| 1 | Contralateral | † | † | † | † | † | † |
| 2 | Contralateral | 45 | 25 | 20.47 | 31 | 20.47 |
|
| 3 | Contralateral | 63 | 27 | 21.41 | 32 | 20.20 | 18.52 |
| 4 | Bilateral | 69 | 17 | 18.65 | 14 | 16.73 | −17.65 |
| 5 | Bilateral | 46 | 15 | 19.51 | 13 | 19.19 | −13.33 |
| 6 | Bilateral | 42 | 10 | 18.06 | 14 | 19.20 |
|
| 7 | Bilateral | 59 | 15 | 26.50 | 23 | 19.30 |
|
| 8 | Bilateral | † | † | † | † | † | † |
FDI: first dorsal interosseous; ID: participant identifier; ms: milliseconds; NA: not assessed at baseline; NC: not calculated due to missing baseline data; RMT: resting motor threshold; ∆: change; †: missing data; % MSO: percentage of maximum stimulator output. Motor mapping testing intensity was 110% RMT (resting motor threshold). MEP latency durations are reported using the mean time (ms). Bolded values are considered significant defined as ≥20% mapping response sites.
Figure 4TMS-derived motor map of (a) nonlesioned and (b) lesioned hemispheres of participant 2 with the grid centered on the TMS-derived motor hotspot. The brain reconstruction has been rotated to allow for a direct view of the TMS-derived motor hotspot. Grey grid points signify no MEP responses, and teal grid points signify MEP responses > 50 μV (microvolts). The color bar represents the range of amplitude of MEP responses in μV. The range in the amplitude color bar is dependent on the magnitude of the responses observed. Note: ranges are consistent across pre- and posttesting sessions but may differ across hemispheres. CST: corticospinal tract; MEP: motor-evoked potential; TMS: transcranial magnetic stimulation.